What was Scope Fluidics SA’s price range in the past 12 months?
Scope Fluidics SA lowest stock price was zł 109.00 and its highest was zł 159.80 in the past 12 months.
What is Scope Fluidics SA’s market cap?
Scope Fluidics SA’s market cap is zł 458.13M.
When is Scope Fluidics SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scope Fluidics SA’s earnings last quarter?
Scope Fluidics SA released its earnings results on Sep 18, 2026. The company reported -zł 3.197 earnings per share for the quarter.
Is Scope Fluidics SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Scope Fluidics SA pay dividends?
Scope Fluidics SA pays a Notavailable dividend of zł 85.57 which represents an annual dividend yield of ―. See more information on Scope Fluidics SA dividends here
What is Scope Fluidics SA’s EPS estimate?
Scope Fluidics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scope Fluidics SA have?
Scope Fluidics SA has 3,168,271 shares outstanding.
What happened to Scope Fluidics SA’s price movement after its last earnings report?
Scope Fluidics SA reported an EPS of -zł 3.197 in its last earnings report. Following the earnings report the stock price went down -0.314%.
Which hedge fund is a major shareholder of Scope Fluidics SA?
Currently, no hedge funds are holding shares in PL:SCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scope Fluidics SA
Scope Fluidics S.A. is a biotechnology firm dedicated to conceiving and advancing initiatives that harness microfluidic technologies within medical diagnostics and the broader healthcare landscape. Among its key offerings is BacterOMIC, a specialized system for conducting antibiotic susceptibility testing. This enterprise, established in 2010, conducts its operations from Warsaw, Poland.